Labcorp First National Laboratory to Offer Monkeypox Test

Labcorp plans laboratory expansion in Japan through BML collaboration

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 28, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services.